Insta
Covax Initiative Asks WHO To Expedite Emergency Use Listing Of Bharat Biotech's Covaxin
Bharat Biotech’s COVAXIN
The international COVID-19 vaccine sharing initiative called Covax has asked the World Health Organisation (WHO) to expedite the approval for Hyderabad-based Bharat Biotech’s Covaxin which is the first indigenously developed Indian vaccine against COVID-19, reports Economic Times.
In a meeting held on Friday (21 May), Covax facility experts from India and other nations recommended the approval of Covaxin and Russia's Sputnik V. This gains significance as WHO’s approval is a prerequisite for any COVID-19 vaccine to be included under the Covax for distribution.
It should be noted that so far, the WHO has only given approvals to the vaccines from Europe and North America.
Also, in a meeting yesterday (24 May), External Affairs Secretary Harsh Vardhan Shringla is said to have assured Bharat Biotech of the “fullest support” of diplomatic establishment in securing the approvals from the WHO and important countries.
Dr Krishna Ella led company had submitted its expression of interest for an emergency use listing (EUL) of Covaxin to WHO in April. Following this, the WHO had asked Bharat Biotech for additional details. The company is expected to submit its final dossier of details soon.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest
